In Hiroshima Prefecture, Japan
Jpn. ). Infect. Dis., 53, 2000 present reglmenS Of the combined therapy have to be further Viro1., 37, 303-306. evaluated. lt will be also important to take measures fわr 2. Hoshiba, T.,Asamoto,A. and Yabuki,A. (1998): Decreased preventmg mother-to-child CMV infection, such as treatment incidence ofanti-cytomegalovirus antibody positive preg- with hyperimmune anti-CMV sera or vaccination (4). nant women. Nihon-Rinsho, 56, 193-I 96 (in Japanese). 3. Kovacs, A., Schluchter, M., Easley, K., Demmler, G., Shearer, W., La Russa, P., Pitt, J., Cooper, E., Goldfarb, REFERENCES J., Hodes, D., Kattan, M. and Mclntosh, K. (1999): 】. Hirota, K., Muraguchi, KリWatabe, N., Okumura, M., Cytomegalovirus infection and HIV- 1 disease progres- Kozu, M., Takahashi, K., Machida, Y., Funayama, Y., sion in infants bom to HIV-1-iTlfected women. N. Engl. Oshima, T・ and Numazaki, Y. (1992): Prospective study J. Med., 341, 77-84. on maternal, intrauterine, and perinatal infections with 4. Marodi, L. (2000): CMV in HIV-infected newborns. cytomegalovirus in Japan during 1976-1990. J. Mらd. Pediatr. Res,, 47, 173. Laboratory and Epidemiology Communications The First Reported Case of J叩aneSe Spotted Fever in Hiroshima Prefecture, Japan Shinichi Takao*, Yoshiro Kawadal, Motohiko Ogawa2, shinji Fukuda, Ⅵlkie Shimazu, Masahiro Noda and Shizuyo Tbkumoto Dt'vision ofMicrobio/ogy II. Hiroshima Prefectural Institute ofHealth and EnviflOnment, Minami一machi 1-6-29, Minami-ku, Hir10Shima 734-0007, 1Department of Dermatology, Onomichi Municipal Hospital, Shin-takayama 2-ll 70-I 77, Onomichi 722-8503 and 2Department of Virology II, National Institute of lnfectious Diseases, Toyama 1-23-1, Shinjuku-ku, Too,0 162-8640 Communicated by Hiroo lnouye (Accepted November 21 , 2000) The spotted fever group rickettsioses, which are transmitted by ticks, have a worldwide distribution.
[Show full text]